Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/45003 
Authors: 
Year of Publication: 
2010
Series/Report no.: 
Duisburg Working Papers on East Asian Studies No. 87/2010
Publisher: 
University of Duisburg-Essen, Institute of East Asian Studies (IN-EAST), Duisburg
Abstract: 
Biotechnology is one of the knowledge fields particularly targeted by China, as it is considered to open up windows of opportunity for catch-up to the leading economies. However, the seizing of these opportunities requires the existence of an institutional and organizational structure supportive of the introduction and usage of biotechnological knowledge. The present contribution discusses this problem in its national, regional, and sectoral dimensions. By focusing on the biopharmaceutical sector, it is shown that the regulatory environment and the capital market constitute serious bottlenecks to further development.
Subjects: 
China
health biotechnology
innovation system
pharmaceutical
Document Type: 
Working Paper

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.